Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Selivanova

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Seminars in Cancer Biology|April 2, 1999
Reactivation of mutant p53: a new strategy for cancer therapyG Selivanova, T Kawasaki, L Ryabchenko, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Small molecules that reactivate mutant p53V J N Bykov, G Selivanova, K G Wiman
Vrachebnoe Delo|December 1, 1976
[Herpetic encephalitis]A A Mikhaĭlenko, I G Selivanova, Z A Smirnova
Molecular and Cellular Biology|April 17, 1999
Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domainG Selivanova, L Ryabchenko, E Jansson, et al.
Oncogene|September 26, 2001
Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathwayJ Falck, C Lukas, M Protopopova, et al.
Apoptosis : an International Journal on Programmed Cell Death|February 28, 2006
HAMLET triggers apoptosis but tumor cell death is independent of caspases, Bcl-2 and p53O Hallgren, L Gustafsson, H Irjala, et al.
Sovetskaia Meditsina|March 1, 1978
[Neurological disorders in insuloma]Z P Kostina, I G Selivanova, A A Skoromets, et al.
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)|January 1, 1990
[Improving the organization and increasing the quality of the treatment of patients with epilepsy]S A Gromov, M F Kataeva, I G Selivanova, et al.
Cell Death and Differentiation|June 28, 2014
Integrated high-throughput analysis identifies Sp1 as a crucial determinant of p53-mediated apoptosisH Li, Y Zhang, A Ströse, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1993
EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteinsL Szekely, G Selivanova, K P Magnusson, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Seminars in Cancer Biology|April 2, 1999
Reactivation of mutant p53: a new strategy for cancer therapyG Selivanova, T Kawasaki, L Ryabchenko, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Small molecules that reactivate mutant p53V J N Bykov, G Selivanova, K G Wiman
Vrachebnoe Delo|December 1, 1976
[Herpetic encephalitis]A A Mikhaĭlenko, I G Selivanova, Z A Smirnova
Molecular and Cellular Biology|April 17, 1999
Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domainG Selivanova, L Ryabchenko, E Jansson, et al.
Oncogene|September 26, 2001
Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathwayJ Falck, C Lukas, M Protopopova, et al.
Apoptosis : an International Journal on Programmed Cell Death|February 28, 2006
HAMLET triggers apoptosis but tumor cell death is independent of caspases, Bcl-2 and p53O Hallgren, L Gustafsson, H Irjala, et al.
Sovetskaia Meditsina|March 1, 1978
[Neurological disorders in insuloma]Z P Kostina, I G Selivanova, A A Skoromets, et al.
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)|January 1, 1990
[Improving the organization and increasing the quality of the treatment of patients with epilepsy]S A Gromov, M F Kataeva, I G Selivanova, et al.
Cell Death and Differentiation|June 28, 2014
Integrated high-throughput analysis identifies Sp1 as a crucial determinant of p53-mediated apoptosisH Li, Y Zhang, A Ströse, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1993
EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteinsL Szekely, G Selivanova, K P Magnusson, et al.
Pageof 5